BLFS - BioLife Solutions GAAP EPS of -$0.67 misses by $0.29 revenue of $33.3M in-line
2023-11-09 16:09:45 ET
- BioLife Solutions press release ( NASDAQ: BLFS ): Q3 GAAP EPS of -$0.67 misses by $0.29 .
- Revenue of $33.3M (-18.2% Y/Y) in-line.
- Continues to expect its full year 2023 revenue, which contains no COVID related revenue, at the low end of the previously announced guidance range of $144 million to $158 million.
For further details see:
BioLife Solutions GAAP EPS of -$0.67 misses by $0.29, revenue of $33.3M in-line